Rothschild & Co Redburn upgraded Icon (ICLR) to Buy from Neutral with a price target of $236, up from $184. The company’s bookings are likely return to year-over-year growth in Q3, confirming that the demand weakness seen over the past four quarters has been cyclical, not structural, the analyst tells investors in a research note. Rothschild expects Icon’s revenue growth to resume in fiscal 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- Icon price target raised to $224 from $222 at Baird
- ICON plc Announces Participation in September 2025 Investor Conferences
- AstraZeneca and Icon Plc’s Study on ATTR Amyloidosis: Key Insights for Investors
- ICON plc Releases Interim Financial Statements for 2025
- Icon downgraded to Neutral from Buy at Citi